U.S. federal trademark · Serial No. 76232602
Neurological disease therapeutic agents, namely, small molecules, proteins or conditioned media, for the treatment of neurological diseases; living cells which produce molecules to rescue and preserve nerve cells for scientific, laboratory or medical research use; bioassay system containing four phenotypes dopaminergic, GABAergic, serotonergic and cholinergic neurons, used to determine whether small molecules, proteins, and/or conditioned media from cells selectively prevent death of nerve cells
Custom manufacture of cell lines and molecules for others
Living cells which produce molecules to rescue and preserve nerve cells for medical use; pharmaceuticals for degenerative nerve diseases
Biotechnology research and development services; providing access via license agreements to cell lines for research and development by others; bioassay services, namely, services to detect specific neurotrophic factors in clinical research
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.